Related references
Note: Only part of the references are listed.Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats
Zheng Wang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2011)
β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis
Ingo Strack et al.
LABORATORY INVESTIGATION (2011)
New Insights into Autoimmune Cholangitis through Animal Models
Michael Trauner et al.
DIGESTIVE DISEASES (2010)
Bone Marrow Transplantation Demonstrates Medullar Origin of CD34(+) Fibrocytes and Ameliorates Hepatic Fibrosis in Abcb4(-/-) Mice
Martin Roderfeld et al.
HEPATOLOGY (2010)
Effectiveness of the PPARγ agonist, GW570, in liver fibrosis
Liu Yang et al.
INFLAMMATION RESEARCH (2010)
Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis
Takashi Naito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor et al.
HEPATOLOGY (2009)
Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats
Makoto Kawai et al.
HYPERTENSION RESEARCH (2009)
Matrix Metalloproteinase (MMP)-1 and MMP-3 Induce Macrophage MMP-9: Evidence for the Role of TNF-α and Cyclooxygenase-2
Michel Steenport et al.
JOURNAL OF IMMUNOLOGY (2009)
Hepatocyte expression of angiotensin II type 1 receptor is downregulated in advanced human liver fibrosis
Sigrid Schulte et al.
LIVER INTERNATIONAL (2009)
Suppression of Experimental Autoimmune Uveitis by Angiotensin II Type 1 Receptor Blocker Telmisartan
Yoko Okunuki et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Primary sclerosing cholangitis
Marina G. Silveira et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
The challenges in primary sclerosing cholangitis - Aetiopathogenesis, autoimmunity, management and malignancy
Tobias J. Weismueller et al.
JOURNAL OF HEPATOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet
Haiyan Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Endothelin-1 - Mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes
Shaoqing He et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/-) mice harbouring chronic cholangitis
Karl Esten Nakken et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
How variable are hydroxyproline determinations made in different samples of the same liver?
Ana Thereza B. Gomes et al.
CLINICAL BIOCHEMISTRY (2006)
Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice
Paraskevi A. Farazi et al.
CANCER RESEARCH (2006)
Angiotensin II type I receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
Tomofumi Takaya et al.
ATHEROSCLEROSIS (2006)
Impact of inhibitors of the renin-angiotensin-aldosterone system on liver fibrosis and portal hypertension
U. Tox et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes
Y Popov et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatic fibrogenesis requires sympathetic neurotransmitters
JA Oben et al.
GUT (2004)
Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system
TW Kurtz et al.
JOURNAL OF HYPERTENSION (2004)
Regurgitation of bile acids from leaky sclerosing cholangitis in Mdr2 (Abcb4) bile ducts causes knockout mice
P Fickert et al.
GASTROENTEROLOGY (2004)
Dual inhibition of β-adrenergic and angiotensin II receptors by a single antagonist -: A functional role for receptor-receptor interaction in vivo
L Barki-Harrington et al.
CIRCULATION (2003)
Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury
JA Oben et al.
HEPATOLOGY (2003)
Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice
JA Oben et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4
K Kanno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Reversal of left ventricular remodeling: Role of the endothelin pathway
JR Teerlink
JOURNAL OF CARDIAC FAILURE (2002)
Inhibition of rat liver fibrogenesis through noradrenergic antagonism
L Dubuisson et al.
HEPATOLOGY (2002)
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
R Bataller et al.
GASTROENTEROLOGY (2000)
Share Paper
